These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34945016)

  • 1. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.
    Głuszyńska P; Lemancewicz D; Dzięcioł JB; Razak Hady H
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.
    Sasaki A; Nitta H; Otsuka K; Umemura A; Baba S; Obuchi T; Wakabayashi G
    Front Endocrinol (Lausanne); 2014; 5():164. PubMed ID: 25386164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.
    Laursen TL; Hagemann CA; Wei C; Kazankov K; Thomsen KL; Knop FK; Grønbæk H
    World J Hepatol; 2019 Feb; 11(2):138-149. PubMed ID: 30820265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
    Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.
    Pedersen JS; Rygg MO; Serizawa RR; Kristiansen VB; Albrechtsen NJW; Gluud LL; Madsbad S; Bendtsen F
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
    Hafeez S; Ahmed MH
    J Obes; 2013; 2013():839275. PubMed ID: 23431426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
    Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A
    Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
    Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
    Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
    Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
    Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
    Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.